PCSK-9 inhibitors for hyperlipidemia : a review of the comparative clinical effectiveness /

Alirocumab and evolocumab are expensive drugs (annual cost per patient > Can

Saved in:

Bibliographic Details
Online Access:	http://www.ncbi.nlm.nih.gov/books/NBK524911/ Full text
Main Authors:	Banerjee, Srabani (Author), Wells, Charlotte (Clinical reviewer) (Author), Grobelna, Aleksandra (Author)
Format:	Electronic eBook
Language:	English
Published:	Ottawa : CADTH, 2017
Series:	Rapid response report (Canadian Agency for Drugs and Technologies in Health)
Subjects:	Hyperlipidemias > drug therapy. Review. Tables.

Internet